Robert Igarashi
Company: Kiadis
Job title: Head of Discovery & Preclinical Development
Seminars:
PANEL DISCUSSION: Leveraging Different Innate Cell Types for Therapeutic Efficacy in Oncology & Beyond 3:00 pm
With significant work taking place to understand the potential of novel innate cell types such as macrophages, neutrophils and iNKT cells for treatment applications in Oncology, attention also turns to the therapeutic application of innate cells for other important diseases such as inflammatory, autoimmune and fibrosis indications. This panel discussion will cover: Understanding the key…Read more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
FIRESIDE DISCUSSION: Innate Cell Applications in Oncology and Beyond! – A Holistic Perspective 8:30 am
This fireside discussion will cover: Assessing autologous vs allogeneic approaches for innate cell therapy development Understanding how biopharma are coming to terms with the investment landscape in the industry Proposing gold standard strategies for CMC scale up of innate immune therapies Deducing key regulatory barriers that need to be overcome to accelerate the development of…Read more
day: Conference Day One
Chair’s Opening Remarks 8:20 am
day: Conference Day One